Regenerative Medicine: Advances from Developmental to Degenerative Diseases. Blair NF., et al (2017). Advances in Experimental Medicine and Biology Book Series (AEMB, volume 1007): Personalised Medicine Chapter 12 pp 225-239, doi:10.1007/978-3-319-60733-7_12
REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and ‐independent pathways. Drouin‐Ouellet J., et al. (2017). EMBO Molecular Medicine, 9(8), 1117–1131. doi:10.15252/emmm.201607471
Epigenetic resetting of human pluripotency. Guo G., et al. (2017) Development 144: 2748-2763, doi:10.1242/dev.146811.
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. Andrews PW., et al. (2017) Stem Cell Reports, 9(1), 1-4, doi:10.1016/j.stemcr.2017.05.029
Neural grafting for Parkinson’s disease: challenges and prospects. Stoker TB., et al. (2017). Neural Regen Res;12:389-92 doi:10.4103/1673-5374.202935
Chapter 7: Strategies for bringing stem cell-derived dopamine neurons to the clinic. Kirkeby A., et al.(2017) Progress in Brain Research, Volume 230, Issue null, Pages 165-190 doi.org/10.1016/bs.pbr.2016.11.011
Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells. Baker D., et al. (2016). Stem Cell Reports, 7(5), 998-1012, doi.org/10.1016/j.stemcr.2016.10.003.
Comparability: manufacturing, characterisation and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2016. Williams D., et al. Regen Med. (2016), 11 (5), doi:10.2217/rme-2016-0053. Epub 2016 Jul 12.
Making it personal: the prospects for autologous pluripotent stem cell derived therapies.Blair NF., & Barker RA. Regenerative Medicine 2016, doi:10.2217/rme-2016-0057 Epub 2016 Jun 27.
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Daley GQ, et al., Stem Cell Reports. 2016 Jun 14;6(6):787-97. doi:10.1016/j.stemcr.2016.05.001. Epub 2016 May 12.
White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies. Burns AJ, et. al., Dev Biol. (2016) doi:10.1016/j.ydbio.2016.04.001.
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016? Barker RA, et. al., J Parkinsons Dis. 2016;6(1):57-63. doi:10.3233/JPD-160798.
Autophagic response to cell culture stress in pluripotent stem cells. Gregory S., et al., Biochem Biophys Res Commun. 2016 May 6;473(3):758-63, doi:10.1016/j.bbrc.2015.09.080. Epub 2015 Sep 15.